Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 807

Similar articles for PubMed (Select 17938390)

1.

Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.

Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE.

Ann Intern Med. 2007 Oct 16;147(8):525-33.

PMID:
17938390
2.

Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.

Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE.

Circulation. 2007 Sep 25;116(13):1497-503. Epub 2007 Sep 10.

3.

Summaries for patients. Occurrence of venous thromboembolism in women taking low-dose aspirin.

[No authors listed]

Ann Intern Med. 2007 Oct 16;147(8):I34. No abstract available.

PMID:
17938386
4.

Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.

Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S; THRIVE III Investigators.

Thromb Haemost. 2005 Sep;94(3):522-7.

PMID:
16268466
5.

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G; AESOPUS Investigators.

Ann Intern Med. 2009 May 5;150(9):577-85.

PMID:
19414836
6.

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.

Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ.

Arch Intern Med. 2005 Feb 14;165(3):341-5.

PMID:
15710801
7.

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

Ann Intern Med. 2000 May 2;132(9):689-96.

PMID:
10787361
8.

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators.

Arch Intern Med. 2003 Jun 9;163(11):1337-42.

PMID:
12796070
9.
10.

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators.

Ann Intern Med. 2009 Mar 17;150(6):379-86.

PMID:
19293071
11.

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators.

N Engl J Med. 2003 Apr 10;348(15):1425-34. Epub 2003 Feb 24.

12.

Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.

Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Circulation. 2005 Nov 29;112(22):3495-500. Epub 2005 Nov 21.

13.

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M.

J Thromb Haemost. 2006 Jun;4(6):1208-14.

PMID:
16706961
14.

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.

PMID:
18574280
15.

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

Blood. 2002 Mar 15;99(6):1938-42.

16.

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH.

Ann Intern Med. 1991 May 15;114(10):835-9.

PMID:
2014943
17.

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR.

Ann Intern Med. 2001 Sep 4;135(5):322-7.

PMID:
11529695
19.

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group.

Circulation. 2004 Aug 17;110(7):874-9. Epub 2004 Aug 2.

20.

Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging.

Kelly J, Rudd A, Lewis RR, Coshall C, Moody A, Hunt BJ.

Stroke. 2004 Oct;35(10):2320-5. Epub 2004 Aug 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk